Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Russia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20086
20093
20101
20113
20132
20141
20151
20171
20182
20191
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated8
Active, not recruiting3
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion16
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
Bayer2
GlaxoSmithKline2
Pfizer2
Merck Sharp & Dohme LLC1
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension29
Hypertension, Pulmonary10
Eisenmenger Complex2
Scleroderma, Systemic1

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.